Advocacy at a Glance STEVEN GROSSMAN 4/18/24 Advocacy at a Glance STEVEN GROSSMAN 4/18/24 Alliance Releases its FY 25 “Ask” for FDA Funding Read More Advocacy at a Glance STEVEN GROSSMAN 4/12/24 Advocacy at a Glance STEVEN GROSSMAN 4/12/24 Next Budget Webinar on Monday; Hill Days in May Read More Analysis and Commentary STEVEN GROSSMAN 4/12/24 Analysis and Commentary STEVEN GROSSMAN 4/12/24 Alliance’s FY 25 Appropriations Request: Realistic for Meeting FDA’s Needs Read More Advocacy at a Glance STEVEN GROSSMAN 4/5/24 Advocacy at a Glance STEVEN GROSSMAN 4/5/24 Alliance to Announce Its FY 25 Congressional “Ask” Read More Analysis and Commentary STEVEN GROSSMAN 4/5/24 Analysis and Commentary STEVEN GROSSMAN 4/5/24 President’s FY25 Budget Request: FDA Needs More Read More Advocacy at a Glance STEVEN GROSSMAN 3/29/24 Advocacy at a Glance STEVEN GROSSMAN 3/29/24 No Friday Update This Week - Sign Up For The Alliance Budget Series Read More Advocacy at a Glance STEVEN GROSSMAN 3/22/24 Advocacy at a Glance STEVEN GROSSMAN 3/22/24 House and Senate Expected to Complete Action on FY 24 Appropriation Bills Read More Analysis and Commentary STEVEN GROSSMAN 3/22/24 Analysis and Commentary STEVEN GROSSMAN 3/22/24 Preparing for the Alliance’s FY 25 “Ask” Read More Advocacy at a Glance STEVEN GROSSMAN 3/15/24 Advocacy at a Glance STEVEN GROSSMAN 3/15/24 President’s FY 25 Funding Request for FDA - The Facts, The Alliance Response, The Budget Documents Read More Analysis and Commentary STEVEN GROSSMAN 3/15/24 Analysis and Commentary STEVEN GROSSMAN 3/15/24 Q&A About FDA Funding in FY 24 and FY 25 Read More Advocacy at a Glance STEVEN GROSSMAN 3/13/24 Advocacy at a Glance STEVEN GROSSMAN 3/13/24 Special Edition: Alliance Responds to President’s FY25 Budget Read More Advocacy at a Glance STEVEN GROSSMAN 3/8/24 Advocacy at a Glance STEVEN GROSSMAN 3/8/24 House Passes Agriculture/FDA Appropriations Bill Providing Full Year Funding - Senate Action Pending Read More Analysis and Commentary STEVEN GROSSMAN 3/8/24 Analysis and Commentary STEVEN GROSSMAN 3/8/24 Looking Ahead to the President’s FY25 Budget Request Read More Advocacy at a Glance STEVEN GROSSMAN 3/1/24 Advocacy at a Glance STEVEN GROSSMAN 3/1/24 Continuing Resolution Extended with Final Action on Agriculture/FDA Expected Next Week Read More Analysis and Commentary STEVEN GROSSMAN 3/1/24 Analysis and Commentary STEVEN GROSSMAN 3/1/24 Budget Angles: “Not All User Fees Are Alike” and “No Base, No Clarity” Read More Advocacy at a Glance STEVEN GROSSMAN 2/23/24 Advocacy at a Glance STEVEN GROSSMAN 2/23/24 FY 24 Agriculture/FDA Appropriations Bill May - or May Not - Move by March 1 Read More Analysis and Commentary STEVEN GROSSMAN 2/23/24 Analysis and Commentary STEVEN GROSSMAN 2/23/24 5 Things to Know About the FY 24 Appropriations Endgame Read More Advocacy at a Glance STEVEN GROSSMAN 2/16/24 Advocacy at a Glance STEVEN GROSSMAN 2/16/24 FY 2024 Agriculture/FDA Funding–Remaining Issues Read More Analysis and Commentary STEVEN GROSSMAN 2/16/24 Analysis and Commentary STEVEN GROSSMAN 2/16/24 Urging Members of Congress to Request Strong FDA Funding for FY 2025 Read More Advocacy at a Glance STEVEN GROSSMAN 2/9/24 Advocacy at a Glance STEVEN GROSSMAN 2/9/24 Overall Appropriations Prospects: Murky with a Chance of Progress Read More Newer Posts Older Posts
Advocacy at a Glance STEVEN GROSSMAN 4/18/24 Advocacy at a Glance STEVEN GROSSMAN 4/18/24 Alliance Releases its FY 25 “Ask” for FDA Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 4/12/24 Advocacy at a Glance STEVEN GROSSMAN 4/12/24 Next Budget Webinar on Monday; Hill Days in May Read More
Analysis and Commentary STEVEN GROSSMAN 4/12/24 Analysis and Commentary STEVEN GROSSMAN 4/12/24 Alliance’s FY 25 Appropriations Request: Realistic for Meeting FDA’s Needs Read More
Advocacy at a Glance STEVEN GROSSMAN 4/5/24 Advocacy at a Glance STEVEN GROSSMAN 4/5/24 Alliance to Announce Its FY 25 Congressional “Ask” Read More
Analysis and Commentary STEVEN GROSSMAN 4/5/24 Analysis and Commentary STEVEN GROSSMAN 4/5/24 President’s FY25 Budget Request: FDA Needs More Read More
Advocacy at a Glance STEVEN GROSSMAN 3/29/24 Advocacy at a Glance STEVEN GROSSMAN 3/29/24 No Friday Update This Week - Sign Up For The Alliance Budget Series Read More
Advocacy at a Glance STEVEN GROSSMAN 3/22/24 Advocacy at a Glance STEVEN GROSSMAN 3/22/24 House and Senate Expected to Complete Action on FY 24 Appropriation Bills Read More
Analysis and Commentary STEVEN GROSSMAN 3/22/24 Analysis and Commentary STEVEN GROSSMAN 3/22/24 Preparing for the Alliance’s FY 25 “Ask” Read More
Advocacy at a Glance STEVEN GROSSMAN 3/15/24 Advocacy at a Glance STEVEN GROSSMAN 3/15/24 President’s FY 25 Funding Request for FDA - The Facts, The Alliance Response, The Budget Documents Read More
Analysis and Commentary STEVEN GROSSMAN 3/15/24 Analysis and Commentary STEVEN GROSSMAN 3/15/24 Q&A About FDA Funding in FY 24 and FY 25 Read More
Advocacy at a Glance STEVEN GROSSMAN 3/13/24 Advocacy at a Glance STEVEN GROSSMAN 3/13/24 Special Edition: Alliance Responds to President’s FY25 Budget Read More
Advocacy at a Glance STEVEN GROSSMAN 3/8/24 Advocacy at a Glance STEVEN GROSSMAN 3/8/24 House Passes Agriculture/FDA Appropriations Bill Providing Full Year Funding - Senate Action Pending Read More
Analysis and Commentary STEVEN GROSSMAN 3/8/24 Analysis and Commentary STEVEN GROSSMAN 3/8/24 Looking Ahead to the President’s FY25 Budget Request Read More
Advocacy at a Glance STEVEN GROSSMAN 3/1/24 Advocacy at a Glance STEVEN GROSSMAN 3/1/24 Continuing Resolution Extended with Final Action on Agriculture/FDA Expected Next Week Read More
Analysis and Commentary STEVEN GROSSMAN 3/1/24 Analysis and Commentary STEVEN GROSSMAN 3/1/24 Budget Angles: “Not All User Fees Are Alike” and “No Base, No Clarity” Read More
Advocacy at a Glance STEVEN GROSSMAN 2/23/24 Advocacy at a Glance STEVEN GROSSMAN 2/23/24 FY 24 Agriculture/FDA Appropriations Bill May - or May Not - Move by March 1 Read More
Analysis and Commentary STEVEN GROSSMAN 2/23/24 Analysis and Commentary STEVEN GROSSMAN 2/23/24 5 Things to Know About the FY 24 Appropriations Endgame Read More
Advocacy at a Glance STEVEN GROSSMAN 2/16/24 Advocacy at a Glance STEVEN GROSSMAN 2/16/24 FY 2024 Agriculture/FDA Funding–Remaining Issues Read More
Analysis and Commentary STEVEN GROSSMAN 2/16/24 Analysis and Commentary STEVEN GROSSMAN 2/16/24 Urging Members of Congress to Request Strong FDA Funding for FY 2025 Read More
Advocacy at a Glance STEVEN GROSSMAN 2/9/24 Advocacy at a Glance STEVEN GROSSMAN 2/9/24 Overall Appropriations Prospects: Murky with a Chance of Progress Read More
